Arrowstreet Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-47,849
Closed -$164K 2406
2020
Q4
$164K Sell
47,849
-1,055,858
-96% -$2.01M ﹤0.01% 2198
2020
Q3
$1.59M Buy
1,103,707
+333,486
+43% +$594K ﹤0.01% 1659
2020
Q2
$1.54M Buy
770,221
+22,552
+3% +$44.2K ﹤0.01% 1590
2020
Q1
$1.46M Buy
747,669
+55,066
+8% +$164K ﹤0.01% 1176
2019
Q4
$2.87M Buy
+692,603
New +$2.67M 0.01% 1024
2017
Q2
Sell
-514,658
Closed -$7.38M 1219
2017
Q1
$7.38M Buy
+514,658
New +$7.64M 0.03% 467
2016
Q4
Sell
-944,704
Closed -$17.1M 2164
2016
Q3
$17.1M Buy
944,704
+739,291
+360% +$11.9M 0.06% 332
2016
Q2
$2.95M Buy
+205,413
New +$2.79M 0.01% 731
2016
Q1
Sell
-102,219
Closed -$1.36M 1442
2015
Q4
$1.36M Buy
+102,219
New +$1.26M 0.01% 904
2015
Q3
Sell
-62,745
Closed -$505K 1433
2015
Q2
$505K Buy
+62,745
New +$461K ﹤0.01% 978

Other funds holding LXRX